Board Member: Zhi Zhang
Zhi Zhang, M.D., Ph.D.
Department of Natural Sciences, University of Michigan Dearborn,
Dearbon, MI, USA
Dr. Zhang received her medical degree in Clinical Medicine, Beijing Capital Medical University, MSc. in Molecular Neurobiology, at Center for Neural Regeneration and Repair, Beijing Institute of Neuroscience, and her Ph.D. in Biology/Neuroscience at Wesleyan University, Middletown, Connecticut, USA. Zhang’s Research expertise include: 1) The impact of early life experience (such as head trauma, infection) on the neurological, behavioral, cognitive outcomes later in life; 2). Neuroinflammation, ER stress and metabolic dysregulation after pediatric traumatic brain injury; 3). The efficacy of nanotechnology guided drug therapies, such as anti-inflammatory drug conjugates, on the long-term survival and cognitive improvement after pediatric brain injuries (e.g. traumatic brain injury). Most recent publications: 1. Zhang Z, Nam HK, Crouch S, Hatch NE. “Tissue nonspecific alkalin phosphatase function in bone and muscle progenitor cells: control of mitochondrial respiration and ATP production”. Int. J. Mol. Sci. 22(3):1140. (2021). 2. Rizk M*, Vu J*, Zhang Z. “Impact of pediatric traumatic brain injury on hippocampal neurogenesis.” Neural Regen Res. 16(5):926-933. Review (2021). 3. Zhang Z, Lin YA, Kim SY, Su L, Liu J, Kannan RM, Kannan S. “Systemic dendrimerdrug nanomedicines for long-term treatment of mild-moderate cerebral palsy in a rabbit model.” J Neuroinflammation. 17(1):319. (2020).